Inventor

SELVA ENRICO

IT27 patents

⚠️ This page may combine multiple inventors who share the name “SELVA ENRICO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SELVA ENRICO

LEPETIT SPA

Amides of antibiotic GE 2270 factors

Antibiotic A 40926 mannosyl aglycon

Antibiotic A 40926 N-acylaminoglucuronyl aglycons and antiobiotic A 40926 aglycon

Antibiotic A 40926 complex and its pure factors PA, PB, A, B and B0

Antibiotic A 40926 ester derivatives

Antibiotic A/16686 factor A2, the process for the preparation thereof and the co-produced antibiotic A/16686 factors A1 and A3

Antibiotic ge 2270 factors a1, a2, a3 and h

Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T

Glycopeptide antibiotics

Antibiotic GE 2270 factors A1, A2, A3 and H

Antibiotic GE 2270 factors C2a

Antibiotic GE 2270

Antibiotic GE 2270

Antibiotic A 42867 and the addition salts thereof

Antibiotic SB 22484

Nocardia sp. ATCC 53492, or an antibiotic A 42867 producing mutant or variant thereof

Antibiotics GE 37468 A, B and C

Antibiotics GE 37468 A, B and C

VICURON PHARM INC

Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof

Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof

Antibiotics GE 81112 factors A,B,B1, pharmaceutically acceptable salts and compositions, and use thereof

Antibiotics GE 81112 factors A, B, B1, pharmaceutically acceptable salts and compositions, and use thereof

BIOSEARCH ITALIA SPA

Method for selectively enhancing the production of factors A or B0 of antibiotic A 40926 complex

Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T

Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof

NAICONS S C A R L

Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof

NEWRON PHARM SPA

Hydroxylamine derivatives